$CLOW
Cloudweb, Inc.

2021 Q4 Form 10-Q Financial Statement

#000164033421002701 Filed on November 03, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $104.3M $7.560K $11.63M
YoY Change 796.43% -99.93% 210217.36%
% of Gross Profit
Research & Development $0.00 $0.00 $10.03K
YoY Change -100.0%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $104.3M $7.560K $11.64M
YoY Change 796.43% -99.94% 210398.73%
Operating Profit -$9.933K
YoY Change
Interest Expense -$165.9K $9.933K $16.37K
YoY Change 990.14% -39.31% -280.86%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$104.4M -$17.49K -$11.66M
YoY Change 796.68% -99.85% 79851.65%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$104.4M -$17.49K -$11.66M
YoY Change 796.68% -99.85% 79851.63%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$316.0M -$55.40K -$36.92M
COMMON SHARES
Basic Shares Outstanding 63.14M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $0.00 $0.00 $0.00
Short-Term Investments
Other Short-Term Assets $0.00 $0.00 $0.00
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $0.00 $0.00 $0.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $0.00 $0.00 $0.00
Total Long-Term Assets $0.00 $0.00
Total Assets $0.00 $0.00
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $56.11K $56.84K
YoY Change
Accrued Expenses $144.6K $135.3K
YoY Change 34.42%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $157.0K $156.4K
YoY Change 272.47%
Total Short-Term Liabilities $392.6K $376.9K
YoY Change 91.41%
LONG-TERM LIABILITIES
Long-Term Debt $67.33K $67.33K
YoY Change -62.54%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $67.33K $67.33K
YoY Change -62.54%
TOTAL LIABILITIES
Total Short-Term Liabilities $392.6K $376.9K
Total Long-Term Liabilities $67.33K $67.33K
Total Liabilities $459.9K $444.3K
YoY Change 19.51%
SHAREHOLDERS EQUITY
Retained Earnings -$233.2M -$128.8M
YoY Change 81.17%
Common Stock $128.4M $128.4M
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$459.9K -$444.3K -$370.6K
YoY Change
Total Liabilities & Shareholders Equity $0.00 $0.00
YoY Change

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$104.4M -$17.49K -$11.66M
YoY Change 796.68% -99.85% 79851.63%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$6.480K -$4.380K -$7.310K
YoY Change 6.75% -40.08% 79.17%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 6.480K 4.380K 7.310K
YoY Change 6.75% -40.08% 79.17%
NET CHANGE
Cash From Operating Activities -6.480K -4.380K -7.310K
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 6.480K 4.380K 7.310K
Net Change In Cash 0.000 0.000 0.000
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$6.480K -$4.380K -$7.310K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
2160 USD
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
63140557 shares
CY2021Q3 us-gaap Assets Current
AssetsCurrent
0 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
0 USD
CY2021Q3 us-gaap Assets
Assets
0 USD
CY2020Q4 us-gaap Assets
Assets
0 USD
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
56839 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
55409 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
135260 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
107565 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-17493 USD
CY2020Q4 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
2160 USD
CY2021Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
1784 USD
CY2020Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
0 USD
CY2021Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
154198 USD
CY2020Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
39982 USD
CY2021Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
28480 USD
CY2020Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
0 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
376937 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
205116 USD
CY2021Q3 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
0 USD
CY2020Q4 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
3584 USD
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
47998221 shares
CY2021Q3 us-gaap Salaries And Wages
SalariesAndWages
0 USD
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
63140557 shares
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
63140557 shares
CY2020Q3 us-gaap Salaries And Wages
SalariesAndWages
11625000 USD
us-gaap Salaries And Wages
SalariesAndWages
0 USD
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
63140557 shares
CY2021Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
0 USD
CY2020Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
112416 USD
CY2021Q3 us-gaap Notes Payable
NotesPayable
67326 USD
CY2020Q4 us-gaap Notes Payable
NotesPayable
67326 USD
CY2021Q3 us-gaap Liabilities
Liabilities
444263 USD
CY2020Q4 us-gaap Liabilities
Liabilities
384858 USD
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
63140557 shares
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
128437821 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
128437821 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-128785868 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-128726463 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-96216 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-96216 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-444263 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 USD
CY2021Q3 us-gaap Professional Fees
ProfessionalFees
7560 USD
CY2020Q3 us-gaap Professional Fees
ProfessionalFees
5550 USD
us-gaap Professional Fees
ProfessionalFees
29910 USD
us-gaap Professional Fees
ProfessionalFees
18957 USD
CY2021Q3 us-gaap Development Costs
DevelopmentCosts
0 USD
CY2020Q3 us-gaap Development Costs
DevelopmentCosts
10030 USD
us-gaap Development Costs
DevelopmentCosts
0 USD
us-gaap Development Costs
DevelopmentCosts
10030 USD
us-gaap Salaries And Wages
SalariesAndWages
34875000 USD
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
7560 USD
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
11640580 USD
us-gaap Operating Expenses
OperatingExpenses
29910 USD
us-gaap Operating Expenses
OperatingExpenses
34903987 USD
CY2021Q3 us-gaap Interest Expense
InterestExpense
9933 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
16368 USD
us-gaap Interest Expense
InterestExpense
29495 USD
us-gaap Interest Expense
InterestExpense
67568 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-17493 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-11656948 USD
us-gaap Net Income Loss
NetIncomeLoss
-59405 USD
us-gaap Net Income Loss
NetIncomeLoss
-34971555 USD
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.18
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.73
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-384858 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-26780 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-411638 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-15132 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-426770 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
0 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-370584 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
us-gaap Net Income Loss
NetIncomeLoss
-59405 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-335967 USD
CY2020Q1 clow Conversion Of Convertible Notes Into Common Stock Amount
ConversionOfConvertibleNotesIntoCommonStockAmount
9000 USD
us-gaap Net Income Loss
NetIncomeLoss
-34971555 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1800 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-342805 USD
CY2020Q2 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
13800 USD
CY2020Q2 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
11625000 USD
CY2020Q1 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
21801 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
11625000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-11662639 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-11651968 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2020Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
10030 USD
CY2020Q3 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
11625000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-11656948 USD
us-gaap Share Based Compensation
ShareBasedCompensation
34875000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-355973 USD
CY2020Q3 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
7307 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
28480 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
44707 USD
us-gaap Share Based Compensation
ShareBasedCompensation
0 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
25875 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
28480 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25875 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
0 USD
us-gaap Development Costs
DevelopmentCosts
0 USD
us-gaap Development Costs
DevelopmentCosts
10030 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1430 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-6917 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
27695 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
22860 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-28480 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-25875 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
clow Amendment Of Promissory Note To Convertible Note
AmendmentOfPromissoryNoteToConvertibleNote
0 USD
clow Amendment Of Promissory Note To Convertible Note
AmendmentOfPromissoryNoteToConvertibleNote
17033 USD
clow Conversion Of Convertible Notes For Common Stock
ConversionOfConvertibleNotesForCommonStock
0 USD
clow Conversion Of Convertible Notes For Common Stock
ConversionOfConvertibleNotesForCommonStock
9000 USD
us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
0 USD
us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
42908 USD
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
57827097 shares
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
69486 USD
CY2020 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
69486 USD
clow Less Current Portion Of Promissory Note Payable
LessCurrentPortionOfPromissoryNotePayable
-2160 USD
CY2020 clow Less Current Portion Of Promissory Note Payable
LessCurrentPortionOfPromissoryNotePayable
-2160 USD
clow Longterm Promissory Notes Payable
LongtermPromissoryNotesPayable
67326 USD
CY2020 clow Longterm Promissory Notes Payable
LongtermPromissoryNotesPayable
67326 USD
us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
62180 USD
CY2020 us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
34895 USD
CY2021Q3 us-gaap Convertible Debt
ConvertibleDebt
154198 USD
CY2020Q4 us-gaap Convertible Debt
ConvertibleDebt
152398 USD
CY2021Q3 clow Less Current Portion Of Convertible Note Payable
LessCurrentPortionOfConvertibleNotePayable
-154198 USD
CY2020Q4 clow Less Current Portion Of Convertible Note Payable
LessCurrentPortionOfConvertibleNotePayable
-39982 USD
CY2021Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
0 USD
CY2020Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
112416 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1800 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
44707 USD
CY2021Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
154198 USD
CY2020Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
152398 USD
CY2021Q3 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
1784 USD
CY2020Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
3584 USD
CY2021Q3 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
73080 USD
CY2020Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
61684 USD
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2020Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
9000 USD
CY2020Q1 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
3000000 shares
CY2020Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
1.25
us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
a majority of stockholders of our company and board of directors approved a reverse stock split of our issued and outstanding shares of common stock on a basis of up to two hundred (200) old shares for one (1) new share of common stock

Files In Submission

Name View Source Status
0001640334-21-002701-index-headers.html Edgar Link pending
0001640334-21-002701-index.html Edgar Link pending
0001640334-21-002701.txt Edgar Link pending
0001640334-21-002701-xbrl.zip Edgar Link pending
clow-20210930.xsd Edgar Link pending
clow-20210930_cal.xml Edgar Link unprocessable
clow-20210930_def.xml Edgar Link unprocessable
clow-20210930_lab.xml Edgar Link unprocessable
clow-20210930_pre.xml Edgar Link unprocessable
clow_10q.htm Edgar Link pending
clow_10q_htm.xml Edgar Link completed
clow_ex311.htm Edgar Link pending
clow_ex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending